KAM
SPPI

Krensavage Asset Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Krensavage Asset Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,092,162
Closed -$6.95M – 21
2016
Q1 		$6.95M Sell
1,092,162
-5,173
-0.5% -$26.5K 2.49% 15
2015
Q4 		$6.62M Buy
1,097,335
+18,833
+2% +$108K 2.11% 17
2015
Q3 		$6.45M Buy
1,078,502
+234,800
+28% +$1.63M 2.33% 17
2015
Q2 		$5.77M Buy
+843,702
New +$5.36M 2.18% 17

Other funds holding SPPI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Krensavage Asset Management's SPPI Position: Q2 2016 in Review

Krensavage Asset Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2016, closing a stake of 1,092,162 shares — an estimated $6.95M sold.

Krensavage Asset Management first reported a position in SPPI in Q2 2015 and held it in 4 quarters. The position peaked at $6.95M in Q1 2016. 161 funds tracked by Wall St. Rank hold SPPI as of Q2 2016.

  • Krensavage Asset Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • Krensavage Asset Management sold 1,092,162 Spectrum Pharmaceuticals Inc shares in Q2 2016, an estimated $6.95M.
  • Krensavage Asset Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2015 and held it in 4 quarters.
  • Krensavage Asset Management's Spectrum Pharmaceuticals Inc position peaked at $6.95M in Q1 2016.
  • 161 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2016.

Based on Krensavage Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.